Information about PPI in the MErCuRIC study was displayed at a public event launching the NI Cancer Trials Network (NICTN) and NI Cancer Research Consumer Forum (NICRCF) new 5 year Strategy for Personal and Public Involvement in Cancer Research in Northern Ireland. Around 85 research staff, patient representatives and members of the public attended the event on 26 March 2018, held in the Postgraduate Centre of the Belfast City Hospital.
The event, chaired by Margaret Grayson, MErCuRIC patient representative, included a range of researcher and NICRCF speakers. One of the presentations, by Dr Philip Dunne, Centre for Cancer Research and Cell Biology, QUB, looked at the role of the research laboratory in personalised medicine in bowel cancer.
Feedback was very positive about the event, which included participation from a number of charities and organisations providing information stands. The NICTN and NICRCF look forward to feedback about the strategy during a 3 month consultation period.